Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Defibtech to Show New Lifeline PRO AED at Medica 2011

November 17, 2011 5:23 am | News | Comments

DUSSELDORF, Germany--(BUSINESS WIRE)--Defibtech will demonstrate its new Lifeline PRO automated external defibrillator (AED) at Medica 2011, Nov. 16-19, in Dusseldorf, Germany. The Lifeline PRO provides professional responders with full manual control over shock energy and shock delivery.

Gore Receives FDA Approval for Conformable GORE TAG Thoracic Endoprosthesis

November 17, 2011 5:21 am | News | Comments

FLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announced that it has received approval from the US Food and Drug Administration (FDA) to market the Conformable GORE® TAG® Thoracic Endoprosthesis as a minimally invasive treatment for patients...

TandemHeart Included in New Treatment Guidelines

November 17, 2011 5:14 am | News | Comments

PITTSBURGH--(BUSINESS WIRE)--The TandemHeart circulatory support system has been added to the 2011 treatment guidelines coauthored by the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and the Society for Cardiovascular Angiography & Interventions (SCAI).

Advertisement

Clinical Trial Shows Berlin Heart's EXCOR® Pediatric Ventricular Assist Device (VAD) Successfully Bridged 90% of Children with Severe Heart Failure Who Were Waiting for a Heart Transplant

November 17, 2011 5:07 am | News | Comments

THE WOODLANDS, Texas & BERLIN--(BUSINESS WIRE)--The Berlin Heart Group announced today that clinical trial data were presented this morning at the “Scientific Sessions 2011” annual meeting of the American Heart Association (AHA). These data showed that, in a clinical trial...

Therix Medical Spins Out Bluegrass Vascular Technologies, Developer of the Surfacer Inside-Out Access Catheter System

November 16, 2011 5:21 am | News | Comments

LEXINGTON, Ky.--(BUSINESS WIRE)--Medical technology incubator Therix Medical has announced the launch of spin-out Bluegrass Vascular Technologies, a stand-alone company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures.

BIOTRONIK Announces Six-Month Coronary Stenting ENERGY Registry Results Presented at TCT 2011

November 15, 2011 5:59 am | News | Comments

BUELACH, Switzerland--(BUSINESS WIRE)--BIOTRONIK AG announced that the six-month results of the ENERGY Registry were presented last week by Prof. Raimund Erbel at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference. This all-comers registry is investigating...

Toshiba's Cardiovascular Systems Make Transradial Approach Easier and Safer

November 15, 2011 5:56 am | News | Comments

TUSTIN, Calif.--(BUSINESS WIRE)--Performing cardiac catheterizations through the radial artery is proven to make exams safer for patients while frequently reducing post-procedure hospital stay times. To conduct radial interventions from both the right and left side, Harrison Medical Center in Bremerton, Wash...

BioVentrix Completes Enrollment in Pilot Human Clinical Trial of the PliCath HFâ„¢ Heart Failure Treatment System

November 15, 2011 5:39 am | News | Comments

SAN RAMON, Calif.--(BUSINESS WIRE)--BioVentrix, developer of the PliCath HF™ System, today announced the achievement of a significant milestone – completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).

Advertisement

ZOLL LifeVest Wearable Defibrillator Highly Cost-Effective Therapy

November 15, 2011 5:32 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that data showing the cost-effectiveness of the LifeVest® Wearable Defibrillator was presented...

DSM ComfortCoat® Hydrophilic Coating Utilized in New Drug Eluting Stent Delivery System from CID SpA

November 15, 2011 5:06 am | News | Comments

BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science, today announced the use of its ComfortCoat® hydrophilic coating on the delivery system of CID SpA's new Cre8™ Drug Eluting Stent (DES), CE marked the 16th of July 2011.

Positive Clinical Study Results for BSP's HyperQ Technology will be reported in American Journal of Cardiology

November 15, 2011 4:56 am | News | Comments

Tel - Aviv, November 14, 2011 - BSP Biological Signal Processing Ltd. (BSP) (TASE: BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study...

Leadless pacemaker brings new hope to cardiac patients

November 15, 2011 4:50 am | News | Comments

Cambridge, MA and UK– November 14, 2011 – Cambridge Consultants, a leading technology design and development firm, today unveiled how it has collaborated with start-up company EBR Systems to develop the world's first wireless pacing system. With cardiac stimulation leads...

North Carolina Medicaid Issues Favorable Policy on ZOLL LifeVest Wearable Defibrillator

November 14, 2011 5:45 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), the manufacturer of the LifeVest® Wearable Defibrillator, announced today that North Carolina's Division of Medical Assistance has established a coverage policy for wearable cardioverter defibrillators.

Advertisement

New Data Confirms Early Implantation of Impella 2.5 Prior to PCI Improves Survival in Shock Patients

November 14, 2011 5:31 am | News | Comments

DANVERS, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new results from a multicenter retrospective study demonstrating that early initiation of support with Impella® 2.5...

Neovasc Inc. Receives CE Mark for Reducer Product to Treat Refractory Angina

November 14, 2011 5:17 am | News | Comments

November 14, 2011 - Vancouver, BC, Canada - Neovasc Inc. (TSXV: NVC), today announced that it has received the CE mark designation for its Reducerâ„¢ product for the treatment of refractory angina. CE marking confirms that the Reducer conforms to the applicable European Directive...

Australian medical technologies to scope the European market

November 14, 2011 4:46 am | News | Comments

A wearable, discreet cardiovascular vital signs monitor developed at the University of Technology, Sydney (UTS) and a portable device for diagnosing the severity of whiplash from The University of Queensland (UQ) are among more than 25 cutting edge medical innovations that leading university research commercialisation...

InSeal Medical Announces Patients Successfully Treated with Novel Intravascular Large Bore Puncture Closure Device

November 11, 2011 4:59 am | News | Comments

SAN FRANCISCO & CAESAREA, Israel--(BUSINESS WIRE)--InSeal Medical Ltd., developer of percutaneous vascular closure devices for large bore punctures, today announced the successful treatment of three patients with its investigational intravascular large bore puncture closure device.

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

November 11, 2011 4:57 am | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Six-month results from the DELUX registry and 12-month results from the PEPPER study, both demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon, were presented on Tuesday and Wednesday...

Fresenius Medical Care introduces 2008K@homeâ„¢ hemodialysis delivery system in North America

November 11, 2011 4:50 am | News | Comments

BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world's largest provider of dialysis products and services, today introduced the 2008K@home...

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

November 11, 2011 4:40 am | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the feasibility study results for the company's Porticoâ„¢ Transcatheter Aortic Heart Valve, presented at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Flexible Stenting Solutions, Inc. Announces First Implant of the 200 mm FlexStent® Femoropopliteal Self Expanding Stent System

November 10, 2011 5:56 am | News | Comments

EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions, Inc. (FSS), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today the successful implantation of its 200 mm FlexStent® Femoropopliteal Self Expanding Stent System...

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 10, 2011 5:22 am | News | Comments

DANVERS, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the final analysis from the PROTECT II trial at the annual 2011 Transcatheter Cardiovascular Therapeutics (TCT) meeting.

1st Findings on Exercise Performance with SynCardia's Total Artificial Heart Published in The Journal of Heart and Lung Transplantation

November 10, 2011 5:02 am | News | Comments

TUCSON, Ariz. – Nov. 10, 2011 – In the November issue of The Journal of Heart and Lung Transplantation (JHLT), Virginia Commonwealth University (VCU) Medical Center in Richmond published the first findings demonstrating that physical exercise and measurable rehabilitation are feasible with the SynCardia...

Svelte Medical Systems Announces Treatment of First Patient in the DIRECT Drug-Eluting Stent Study

November 9, 2011 4:44 am | News | Comments

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced treatment of the first patient in the DIRECT (Direct-on-a-wire Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study at Auckland City Hospital in Auckland, New Zealand.

Positive Long Term Clinical Data of the Cappella Sideguard® Stent System Announced at TCT 2011

November 9, 2011 4:38 am | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced today at the 2011 TCT (Transcatheter Cardiovascular Therapeutics) Conference in San Francisco...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading